Sox-8 Activators
The Sox-8 Activators class encompasses a diverse group of chemical compounds that can either directly or indirectly enhance the functional activity of Sox-8, a transcription factor. These chemicals influence a variety of cellular signaling pathways that are crucial for the functional activation of Sox-8. For example, Forskolin activates adenylyl cyclase, leading to an increase in intracellular cAMP levels and subsequently the activation of protein kinase A (PKA). PKA can directly phosphorylate Sox-8, thus enhancing its transcriptional activity. Similarly, insulin activates the PI3K/Akt pathway, which also modulates the activity of Sox-8 and enhances its transcriptional activity.
On the other hand, some chemicals in this class can indirectly activate Sox-8 by altering the balance of cellular signals. An example of this is LY294002, a PI3K inhibitor, which reduces Akt activity thereby altering the cellular signaling environment and leading to increased activation of other pathways that enhance Sox-8 activity. Another example is the compound Staurosporine, a potent inhibitor of protein kinases, which leads to altered cellular signaling that can indirectly activate Sox-8. Similarly, the compound Y-27632 inhibits ROCK, leading to changes in the actin cytoskeleton and influencing the activity of Sox-8. Furthermore, Lithium Chloride inhibits GSK3β, leading to an increase in β-catenin stability and Wnt signaling. Since Sox-8 is a known target of Wnt signaling, its activity can be enhanced by Lithium Chloride. Therefore, each compound in this class activates Sox-8 either directly or indirectly, through a variety of biochemical and cellular pathways, leading to enhanced functional activity of Sox-8.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor which activates the JNK signaling pathway. Sox-8, being a transcription factor, can be functionally activated when this pathway is triggered, leading to the enhanced transcription of its target genes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a potent activator of adenylyl cyclase, leading to an increase in intracellular cAMP levels. This results in the activation of PKA, which can phosphorylate Sox-8 and increase its transcriptional activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate the PI3K/Akt pathway, which has been shown to modulate the activity of numerous proteins, including Sox-8. This activation leads to an increase in Sox-8's activity, enhancing the transcription of its target genes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates the PKC pathway, which can phosphorylate and activate Sox-8. This leads to an increased functional activity of Sox-8, enhancing the transcription of its target genes. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases, leading to an increase in the phosphorylation and activation of many proteins, including Sox-8. This leads to an increase in Sox-8's activity, enhancing the transcription of its target genes. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like okadaic acid, is a potent inhibitor of protein phosphatases, leading to an increase in the phosphorylation and activation of many proteins, including Sox-8. This leads to an increase in Sox-8's activity, enhancing the transcription of its target genes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, leading to decreased Akt activity. This alters the balance of signals in the cell, potentially leading to increased activation of other pathways that can enhance Sox-8 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, leading to altered signaling within the cell. This can indirectly lead to the activation of Sox-8, enhancing the transcription of its target genes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
LiCl inhibits GSK3β, leading to an increase in β-catenin stability and Wnt signaling. Sox-8 is a known target of Wnt signaling, and thus its activity can be enhanced by LiCl. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB 431542 is an inhibitor of the TGF-β pathway, which can indirectly lead to the activation of Sox-8. This leads to an increase in Sox-8's activity, enhancing the transcription of its target genes. | ||||||